Cognetivity Neurosciences Ltd. (CGNSF) stock profile

Frequently asked questions

What does Cognetivity Neurosciences Ltd. (CGNSF) do?

Cognetivity Neurosciences Ltd. is a healthcare firm focused on advanced cognitive assessment. The company has developed a sophisticated platform for cognitive testing, designed for use across diverse settings including medical facilities, commercial environments, and by individual consumers. This innovative system's primary goal is to identify the very first signs of cognitive impairment through a comprehensive evaluation of broad brain functions, thereby assisting in the diagnosis of conditions like dementia. In addition to its core platform, Cognetivity also provides OptiMind, a dedicated wellness application. Established in 2015, the company initially operated under the name Utor Capital Corp. before officially rebranding to Cognetivity Neurosciences Ltd. in December 2017. Its main offices are situated in Vancouver, Canada.

Where is CGNSF stock listed?

Cognetivity Neurosciences Ltd. trades under the ticker CGNSF on OTC.

How can I research CGNSF's financials and filings?

Vantafin provides Cognetivity Neurosciences Ltd.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the CGNSF profile.